Assenagon Asset Management
ACAD icon

Assenagon Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Assenagon Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$589K Sell
2025
Q2 		$36.9M Sell
2025
Q1 		$60.8M Buy
2022
Q3 		– Sell
2022
Q2 		$1.69M Sell
2022
Q1 		$3.6M Buy
2021
Q4 		$2.36M Buy
2021
Q3 		$236K Buy
2019
Q4 		– Sell
2019
Q3 		$713K Buy